Abstract
Myelodysplastic syndromes (MDS) are a group of clonal hematologic disorders found predominantly in the elderly. The molecular mechanisms underlying the development of MDS remain obscure. In order to begin to identify tumor suppressor genes involved in these disorders, we performed a detailed microsatellite allelotype of chromosomal deletions associated with MDS. DNAs from both bone marrow and peripheral blood of 32 MDS patients were studied using 84 highly informative microsatellite markers on all autosomal arms, excluding the short arms of the acrocentric chromosomes. A high percentage of loss of heterozygosity (LOH) was identified on chromosome 5q (40% of informative cases), 7q (45%), 17p (23%) and 20q (20%), which corresponds to the most common cytogenetic abnormalities reported in MDS. In addition, a high incidence of LOH (⩾20%) was observed on chromosomal arms which had not been previously reported including 1p (36%), 1q (35%), and 18q (23%). This extensive allelotype analysis focuses attention on several novel genomic regions that probably contain novel tumor suppressor genes whose loss of function contributes to the development of MDS.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Koeffler HP . Myelodysplastic syndromes (preleukemia) Semin Hematol 1986 23: 284–299
Janssen JWG, Buschle M, Layton M, Drexler HG, Lyons J, Van den Berghe H, Heimpel H, Kubanek B, Kleihauer E, Mufti GJ, Bartram CR . Clonal analysis of myelodysplastic syndromes: evidence of multipotential stem cell origin Blood 1989 73: 248–254
Bennett JM, Catovsky D, Flandrin G, Galton DA, Gralnick HR, Sultan C . Proposals for the classification of the myelodysplastic syndromes Br J Haematol 1982 51: 189–199
Marshall CJ . Tumor suppressor genes Cell 1991 64: 313–326
Goddard AD, Solomon E . Genetic aspects of cancer. In: Advances in Human Genetics Plenum Press: New York 1993 pp 321–326
Horrigan SK, Westbrook CA, Kim AH, Banerjee M, Stock W, Larson RA . Polymerase chain reaction-based diagnosis of del 5q in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval Blood 1996 88: 2665–2670
Fischer K, Frohling S, Scherer SW, Brown JM, Scholl B, Stigenbauer S, Tsui LC, Lichter P, Dohner H . Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias Blood 1997 89: 2036–2041
Matsushima T, Murakami H, Kim K, Uchiumi H, Murata N, Tamura J, Sawamura M, Karasawa M, Naruse T, Tsuchiya J . Steroid-responsive pulmonary disorders associated with myelodysplastic syndromes with der(1q;7p) chromosomal abnormality Am J Hematol 1995 50: 110–115
Boultwood J, Fidler C . Chromosomal deletions in myelodysplasia Leuk Lymphoma 1995 17: 71–78
Vogelstein B, Fearon EE, Kern S, Hamilton SR, Preisinger AC, Nakamura Y, White R . Allelotype of colorectal carcinoma Science 1989 244: 207–211
Zhao N, Stoffel A, Wang PW, Eisenbart JD, Espinosa R, Larson RA, LeBeau MM . Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1–1.5Mb and preparation of a PAC-based physical map Proc Natl Acad Sci USA 1997 94: 6948–6953
Tsuchiya E, Nakamura Y, Weng SY, Nakagawa K, Tsuchiya S, Sugano H, Kitagawa T . Allelotype of non-small cell lung cacinoma-comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma Cancer Res 1992 52: 2478–2481
Sankar M, Tanaka K, Kumaravel TS, Arif M, Shintai T, Yagi S, Kyo T, Dohy H, Kamada N . Identification of a commonly deleted region at 17p13.3 in leukemia and lymphoma associated with 17p abnormality Leukemia 1998 12: 510–516
Neuman WL, Rubin CM, Rios RB, Larson RA, Le Beau MM, Rowley JD, Vardiman JW, Schwartz JL, Farber RA . Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders Blood 1992 79: 1501–1510
Sole F, Prieto F, Badia L, Woessner S, Florensa L, Caballin MR, Coll MD, Besses C, Sans-Sabrafen J . Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes Cancer Genet Cytogenet 1992 64: 12–20
Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X . Monallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers Cell 1997 90: 809–819
White PS, Maris JM, Beltinger C, Sulman E, Marshall HN, Fujimori M, Kaufman BA, Biegel JA, Allen C, Hilliard C, Valentine MB, Look AT, Enomoto H, Sakiyama S, Brodeur GM . A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2–36.3 Proc Natl Acad Sci USA 1995 92: 5520–5524
Praml C, Finke LH, Herfarth C, Schlag P, Schwab M, Amler L . Deletion mapping defines different regions in 1p34.2-pter that may harbor genetic information related to human colorectal cancer Oncogene 1995 11: 1357–1362
Yeh S-H, Chen P-J, Chen H-L, Lai M-Y, Wang C-C, Chen D-S . Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas Cancer Res 1994 54: 4188–4192
Asimakopoulos FA, Green AR . Deletions of chromosome 20q and the pathogenesis of myeloproliferative disorders Br J Haematol 1996 95: 219–226
Lai JL, Preudhomme C, Zandecki M, Flactif M, Vanrumbeke M, Lepelley P, Wattel E, Fenaux P . Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoiesis and a high incidence of P53 mutations Leukemia 1995 9: 370–381
Mori N, Morosetti R, Lee S, Spira S, Ben-Yehuda D, Schiller G, Landolfi R, Mizoguchi H, Koeffler HP . Allelotype analysis in the evolution of chronic myelocytic leukemia Blood 1997 90: 2010–2014
Nomoto S, Haruki N, Kondo M, Konishi H, Takahashi T, Takahashi I, Takahashi T . Search from mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers Cancer Res 1998 58: 1380–1383
Gedler SJ, Cohen EP, Craston A, Duhig T, Johnstone G, Barnes D . The locus of the polymorphic epithelial mucin (PEM) tumor antigen on chromosome 1q shows a high frequency of alteration in primary human breast tumors Int J Cancer 1990 45: 431–435
Chen LC, Dollbaum C, Smith HS . Loss of heterozygosity on chromosome 1q in human breast cancer Proc Natl Acad Sci USA 1989 86: 7204–7207
Johansson B, Brondum-Nielsen K, Billstrom R, Schiodt I, Mitelman F . Translocations between the long arms of chromosomes 1 and 5 in hematologic malignancies are strongly associated with neoplasms of the myeloid lineages Cancer Genet Cytogenet 1997 99: 97–101
Perkins D, Brennan S, Carstairs K, Bailey D, Pantalony D, Poon A, Fernandes B, Dube I . Regional cancer cytogenetics: a report on 1143 diagnostic cases Cancer Genet Cytogenet 1997 96: 64–80
Mogul MJ, Brady K, Brothman AR, Adams R, Peterson FB, Beatty PG . Myelodysplastic syndrome presenting with clonal rearrangement isolated to chromosomal region 1q Cancer Genet Cytogenet 1997 95: 210–212
Uchino S, Tsuda H, Noguchi M, Yokota J, Terada M, Saito T, Kobayashi M, Sugimura T, Hirohashi S . Frequent loss of heterozygosity at the DCC locus in gastric cancer Cancer Res 1992 52: 3099–3102
Huang Y, Boynton RF, Blount PL, Silverstein RJ, Yin J, Tong Y, McDaniel T, Newkirk C, Resau JH, Sridhara R, Reid BJ, Meltzer SJ . Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers Cancer Res 1992 52: 6525–6530
Chenevix-Trech G, Leary J, Kerr J, Michel J, Kefford R, Hurst T, Parosns PG, Friedlander M, Khoo SD . Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus Oncogene 1992 7: 1059–1065
Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R . The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer Cell 1993 75: 1027–1038
Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, Kinzler KW, Vogelstein B . Mutation of a mutL homolog in hereditary colon cancer Science 1994 263: 1625–1629
Thibodeau SN, Bern G, Schaid D . Microsatellite instability in cancer of the proximal colon Science 1993 260: 816–819
Rhyu MG, Park WS, Meltzer SJ . Microsatellite instability occurs frequently in human gastric carcinoma Oncogene 1994 9: 29–32
Risinger JI, Berchuck A, Kohler MF, Watson P, Lynch HT, Boyd J . Genetic instability of microsatellites in endometrial carcinoma Cancer Res 1993 53: 5100–5103
Ben-Yehuda D, Krichevsky S, Caspi O, Rund D, Polliack A, Abeliovich D, Zelig O, Yahalom V, Paltiel O, Or R, Peretz T, Ben-Neriah S, Yehuda O, Rachmilewitz EA . Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype Blood 1996 88: 4296–4303
Zhu YM, Das-Gupta EP, Russel NH . Microsatellite instability and p53 mutations are associated with abnormal expression of the MSH2 gene in adult leukemia Blood 1999 94: 733–740
Tasaka T, Lee S, Spira S, Takeuchi S, Hatta Y, Nagai M, Takahara J, Koeffler HP . Infrequent microsatellite instability during the evolution of myelodysplastic syndrome to acute myelocytic leukemia Leukemia Res 1996 20: 113–117
Kaneko H, Horiike S, Taniwaki M, Misawa S . Microsatellite instability is an early genetic event in myelodysplastic syndrome but is infrequent and not associated with TGF-beta receptor type II gene mutation Leukemia 1996 10: 1696–1699
Harada S, Komatsu H, Seto M, Ni H, Xu JH, Hayami Y, Tsuboi K, Wakita A, Nitta M, Kato T, Ueda R . Microsatellite instability is rare in the clinical course of myelodysplastic syndrome studied with DNA from fresh and paraffin-embedded tissues J Cancer Res Clin Oncol 1998 124: 231–235
Ben-Yehuda D . Microsatellite instability analysis in human leukemia Rev Clin Exp Hematol 1997 3: 71–79
Yamaguchi T, Toguchida J, Yamamuro T, Kotoura Y, Takada N, Kawaguchi N, Kaneko Y, Nkamura Y, Sasaki M, Ishizaki K . Allelotype analysis in osteosarcomas, frequent allele loss on 3q, 13q, 17p, and 18q Cancer Res 1992 52: 2419–2423
Knowles MA, Elder PA, Williamson M, Cairns JP, Shaw ME, Law MG . Allelotype of human bladder cancer Cancer Res 1994 54: 531–538
Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B . Mutation of mitotic checkpoint genes in human cancers Nature 1998 392: 300–303
Acknowledgements
This work was supported in part by National Institutes of Health Grants, the Parker Hughes Trust, C and H Koeffler Research Fund, and Gladys Lichtenstein Leukemia Research Fund. HPK is a member of the Jonsson Comprehensive Cancer Center and holds the endowed Mark Goodson Chair of Oncology Research at Cedars-Sinai Medical Center/UCLA School of Medicine.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Xie, D., Hofmann, WK., Mori, N. et al. Allelotype analysis of the myelodysplastic syndrome. Leukemia 14, 805–810 (2000). https://doi.org/10.1038/sj.leu.2401717
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401717
Keywords
This article is cited by
-
RARβ2 is a candidate tumor suppressor gene in myelofibrosis with myeloid metaplasia
Oncogene (2004)
-
Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype
Leukemia (2002)
-
Preferential expression of the transcription coactivator HTIF1α gene in acute myeloid leukemia and MDS-related AML
Leukemia (2002)